Owens & Minor misses Q3 revenue estimates, reaffirms FY guidance

Reuters10-31

Owens & Minor misses Q3 revenue estimates, reaffirms FY guidance

Overview

Owens & Minor misses analysts' expectations for Q3 revenue
However, adjusted EBITDA beats consensus
Company shifts focus to home-based care, with sale of Products & Healthcare Services

Outlook

Company reaffirms 2025 revenue guidance of $2.76 bln to $2.82 bln
Owens & Minor maintains 2025 adjusted EPS guidance of $1.02 to $1.07
Company expects 2025 adjusted EBITDA between $376 mln and $382 mln

Result Drivers

STRATEGIC SHIFT - Owens & Minor's sale of Products & Healthcare Services segment aligns with focus on home-based care, per CEO Edward A. Pesicka

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q3 Revenue	Miss	$697.30 mln	$1.13 bln (5 Analysts)
Q3 Net Income		-$150.27 mln
Q3 Adjusted EBITDA	Beat	$92.20 mln	$91.59 mln (5 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Owens & Minor Inc is $6.50, about 19.7% above its October 29 closing price of $5.22

Press Release: ID:nBw1NGQ9fa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2579170860?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 04:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579170860","market":"fut","top_or_hot":-1,"title":"Owens & Minor misses Q3 revenue estimates, reaffirms FY guidance","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Owens &amp; Minor misses Q3 revenue estimates, reaffirms FY guidance</title></head><body><p><span>Overview</span></p><ul><li><p>Owens &amp; Minor misses analysts' expectations for Q3 revenue</p></li><li><p>However, adjusted EBITDA beats consensus</p></li><li><p>Company shifts focus to home-based care, with sale of Products &amp; Healthcare Services</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company reaffirms 2025 revenue guidance of $2.76 bln to $2.82 bln</p></li><li><p>Owens &amp; Minor maintains 2025 adjusted EPS guidance of $1.02 to $1.07</p></li><li><p>Company expects 2025 adjusted EBITDA between $376 mln and $382 mln</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>STRATEGIC SHIFT - Owens &amp; Minor's sale of Products &amp; Healthcare Services segment aligns with focus on home-based care, per CEO Edward A. Pesicka</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q3 Revenue</p></td><td><p>Miss</p></td><td><p>$697.30 mln</p></td><td><p>$1.13 bln (5 Analysts)</p></td></tr><tr><td><p>Q3 Net Income</p></td><td></td><td><p>-$150.27 mln</p></td><td></td></tr><tr><td><p>Q3 Adjusted EBITDA</p></td><td><p>Beat</p></td><td><p>$92.20 mln</p></td><td><p>$91.59 mln (5 Analysts)</p></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy\", 1 \"hold\" and 2 \"sell\" or \"strong sell\"</p></li><li><p>The average consensus recommendation for the medical equipment, supplies &amp; distribution peer group is \"buy.\"</p></li><li><p>Wall Street's median 12-month price target for Owens &amp; Minor Inc is $6.50, about 19.7% above its October 29 closing price of $5.22</p></li></ul><p>Press Release: <span>ID:nBw1NGQ9fa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Owens & Minor misses Q3 revenue estimates, reaffirms FY guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOwens & Minor misses Q3 revenue estimates, reaffirms FY guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-31 04:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Owens &amp; Minor misses Q3 revenue estimates, reaffirms FY guidance</title></head><body><p><span>Overview</span></p><ul><li><p>Owens &amp; Minor misses analysts' expectations for Q3 revenue</p></li><li><p>However, adjusted EBITDA beats consensus</p></li><li><p>Company shifts focus to home-based care, with sale of Products &amp; Healthcare Services</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company reaffirms 2025 revenue guidance of $2.76 bln to $2.82 bln</p></li><li><p>Owens &amp; Minor maintains 2025 adjusted EPS guidance of $1.02 to $1.07</p></li><li><p>Company expects 2025 adjusted EBITDA between $376 mln and $382 mln</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>STRATEGIC SHIFT - Owens &amp; Minor's sale of Products &amp; Healthcare Services segment aligns with focus on home-based care, per CEO Edward A. Pesicka</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q3 Revenue</p></td><td><p>Miss</p></td><td><p>$697.30 mln</p></td><td><p>$1.13 bln (5 Analysts)</p></td></tr><tr><td><p>Q3 Net Income</p></td><td></td><td><p>-$150.27 mln</p></td><td></td></tr><tr><td><p>Q3 Adjusted EBITDA</p></td><td><p>Beat</p></td><td><p>$92.20 mln</p></td><td><p>$91.59 mln (5 Analysts)</p></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy\", 1 \"hold\" and 2 \"sell\" or \"strong sell\"</p></li><li><p>The average consensus recommendation for the medical equipment, supplies &amp; distribution peer group is \"buy.\"</p></li><li><p>Wall Street's median 12-month price target for Owens &amp; Minor Inc is $6.50, about 19.7% above its October 29 closing price of $5.22</p></li></ul><p>Press Release: <span>ID:nBw1NGQ9fa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4175","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nL1N3WB1MT:1","article_id":"2579170860","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579170860","pubTimestamp":1761856608,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Owens & Minor misses Q3 revenue estimates, reaffirms FY guidanceOverviewOwens & Minor misses analysts' expectations for Q3 revenueHowever, adjusted EBITDA beats consensusCompany shifts focus to home-b","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4175":"保健护理产品经销商","OMI":"欧麦斯-麦能医疗"},"translate_title":"Owens&Minor未达到第三季度收入预期，重申财年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMI":0.9},"content_text":"Owens & Minor misses Q3 revenue estimates, reaffirms FY guidanceOverviewOwens & Minor misses analysts' expectations for Q3 revenueHowever, adjusted EBITDA beats consensusCompany shifts focus to home-based care, with sale of Products & Healthcare ServicesOutlookCompany reaffirms 2025 revenue guidance of $2.76 bln to $2.82 blnOwens & Minor maintains 2025 adjusted EPS guidance of $1.02 to $1.07Company expects 2025 adjusted EBITDA between $376 mln and $382 mlnResult DriversSTRATEGIC SHIFT - Owens & Minor's sale of Products & Healthcare Services segment aligns with focus on home-based care, per CEO Edward A. PesickaKey DetailsMetricBeat/MissActualConsensus EstimateQ3 RevenueMiss$697.30 mln$1.13 bln (5 Analysts)Q3 Net Income-$150.27 mlnQ3 Adjusted EBITDABeat$92.20 mln$91.59 mln (5 Analysts)Analyst CoverageThe current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy\", 1 \"hold\" and 2 \"sell\" or \"strong sell\"The average consensus recommendation for the medical equipment, supplies & distribution peer group is \"buy.\"Wall Street's median 12-month price target for Owens & Minor Inc is $6.50, about 19.7% above its October 29 closing price of $5.22Press Release: ID:nBw1NGQ9faFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579170860","isCrawlerRequest":true}